Login / Signup

Low-Intensity Statin Plus Ezetimibe Versus Moderate-Intensity Statin for Primary Prevention: A Population-Based Retrospective Cohort Study in Asian Population.

Minji JungBeom-Jin LeeSukhyang LeeJaekyu Shin
Published in: The Annals of pharmacotherapy (2024)
Low-intensity statin plus ezetimibe may be an alternative to moderate-intensity statin for primary prevention. Our findings provide evidence on safety and efficacy of statin therapy in Asian population.
Keyphrases
  • cardiovascular disease
  • coronary artery disease
  • high intensity
  • low density lipoprotein
  • type diabetes